Biblio
“Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.”, J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
, “Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model.”, J Alzheimers Dis, vol. 54, no. 3, pp. 903-912, 2016.
, “Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.”, J Alzheimers Dis, vol. 51, no. 2, pp. 427-37, 2016.
, “Dementia and Rapid Mortality: Who is at Risk?”, J Alzheimers Dis, vol. 53, no. 1, pp. 135-42, 2016.
, “Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia Based on Apraxia Profiles.”, J Alzheimers Dis, vol. 49, no. 3, pp. 593-605, 2016.
, “Dementia Risk and Protective Factors Differ in the Context of Memory Trajectory Groups.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1013-20, 2016.
, “A Depressive Endophenotype for Predicting Cognitive Decline among Mexican American Adults and Elders.”, J Alzheimers Dis, vol. 54, no. 1, pp. 201-6, 2016.
, “Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 3, pp. 743-54, 2016.
, “Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1065-80, 2016.
, “Detection of Alzheimer's Disease by Three-Dimensional Displacement Field Estimation in Structural Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 50, no. 1, pp. 233-48, 2016.
, “Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.”, J Alzheimers Dis, vol. 52, no. 3, pp. 863-73, 2016.
, “Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1259-1272, 2016.
, “Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension.”, J Alzheimers Dis, vol. 49, no. 2, pp. 423-32, 2016.
, “Development of a Proxy-Free Objective Assessment Tool of Instrumental Activities of Daily Living in Mild Cognitive Impairment Using Smart Home Technologies.”, J Alzheimers Dis, vol. 52, no. 2, pp. 509-17, 2016.
, “Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 52, no. 1, pp. 17-24, 2016.
, “Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?”, J Alzheimers Dis, vol. 54, no. 4, pp. 1297-1302, 2016.
, “Diagnosis of Dementia in the Specialist Setting: A Comparison Between the Swedish Dementia Registry (SveDem) and the Registry of Dementias of Girona (ReDeGi).”, J Alzheimers Dis, vol. 53, no. 4, pp. 1341-51, 2016.
, “Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1287-97, 2016.
, “Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 4, pp. 947-55, 2016.
, “Diagnostic Distortions: A Case Report of Progressive Apraxia of Speech.”, J Alzheimers Dis, vol. 53, no. 1, pp. 79-83, 2016.
, “Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 97-106, 2016.
, “Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
, “Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review.”, J Alzheimers Dis, vol. 50, no. 2, pp. 301-34, 2016.
, “Dietary high cholesterol and trace metals in the drinking water increase levels of ABCA1 in the rabbit hippocampus and temporal cortex.”, J Alzheimers Dis, vol. 49, no. 1, pp. 201-9, 2016.
, “Differences in Depressive Patterns According to Disease Severityin Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 91-9, 2016.
,